Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials

Rik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, Alexa Pichet Binette, Divya Bali, Linda Karlsson, Sebastian Palmqvist, Niklas Mattsson-Carlgren, Erik Stomrud, Joseph Therriault, Nesrine Rahmouni, Pedro Rosa-Neto, Emma M. Coomans, Elsmarieke van de Giessen, Wiesje M. van der Flier, Charlotte E. Teunissen, Erin M. Jonaitis, Sterling C. Johnson, Sylvia Villeneuve, PREVENT-AD Research Group, Tammie L. S. Benzinger, Suzanne E. Schindler, Randall J. Bateman, James D. Doecke, Vincent Doré, Azadeh Feizpour, Colin L. Masters, Christopher Rowe, Heather J. Wiste, Ronald C. Petersen, Clifford R. Jack Jr. & Oskar Hansson